Although things appeared to quiet down for COVID-19-related clinical trial news, there were plenty of announcements for other indications. Here’s a look. COVID-19-Related Veru reported the Independent Data Monitoring Committee (IDMC) planned a conditional power analysis of the first 75 patients in its Phase III COVID-19 registration trial of sabizabulin. The trial studied the drug’s effects in […]

It’s a tough market right now for biotech IPOs, but one small company is taking the public leap Friday with a modest initial offering. Blue Water Vaccines raised $20 million in its IPO, pricing shares at $9 apiece late Thursday afternoon. The Cincinnati-based company will use the money primarily to advance a slate of preclinical […]

Due to the increasing incidence of diabetes, obesity and metabolic disease in the United States, it is estimated that one in four patients has some form of fatty liver disease. The impact of this on the healthcare system has been realized and is likely to increase over time. As primary care physicians continue to see […]